Erle T. Mast
2012
In 2012, Erle T. Mast earned a total compensation of $1.3M as EVP, Chief Financial Officer at Clovis Oncology, a 96% increase compared to previous year.
Compensation breakdown
| Bonus | $115,360 |
|---|---|
| Option Awards | $784,435 |
| Salary | $358,570 |
| Other | $15,310 |
| Total | $1,273,855 |
Mast received $784.4K in option awards, accounting for 62% of the total pay in 2012.
Mast also received $115.4K in bonus, $358.6K in salary and $15.3K in other compensation.
Rankings
In 2012, Erle T. Mast's compensation ranked 5,183rd out of 11,487 executives tracked by ExecPay. In other words, Mast earned more than 54.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,183 out of 11,487 | 55th |
Division Manufacturing | 1,812 out of 4,253 | 57th |
Major group Chemicals And Allied Products | 433 out of 1,198 | 64th |
Industry group Drugs | 284 out of 920 | 69th |
Industry Pharmaceutical Preparations | 223 out of 700 | 68th |
Source: SEC filing on April 30, 2015.
Mast's colleagues
We found four more compensation records of executives who worked with Erle T. Mast at Clovis Oncology in 2012.